Physiochemical  	Physiochemical  	 JJ	B-NP
property  	property  	 NN	I-NP
space  	space  	 NN	I-NP
distribution  	distribution  	 NN	I-NP
among  	among  	 IN	O
human  	human  	 JJ	O
metabolites 	metabolites 	 NN	B-NP
,  	,  	 ,	O
drugs  	drugs  	 NNS	O
and  	and  	 CC	O
toxins  	toxins  	 VBG	O
The  	The  	 DT	O
current  	current  	 JJ	O
approach  	approach  	 NN	O
to  	to  	 TO	O
screen  	screen  	 VB	O
for  	for  	 IN	O
drug-like  	drug-like  	 JJ	B-NP
molecules  	molecules  	 NN	I-NP
is  	is  	 VBZ	O
to  	to  	 TO	O
sieve  	sieve  	 VB	O
for  	for  	 IN	O
molecules  	molecules  	 NNS	O
with  	with  	 IN	O
biochemical  	biochemical  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
suitable  	suitable  	 JJ	O
for  	for  	 IN	O
desirable  	desirable  	 JJ	O
pharmacokinetics  	pharmacokinetics  	 NN	B-NP
and  	and  	 CC	O
reduced  	reduced  	 JJ	O
toxicity 	toxicity 	 NN	O
,  	,  	 ,	O
using  	using  	 VBG	O
predominantly  	predominantly  	 RB	O
biophysical  	biophysical  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
of  	of  	 IN	I-NP
chemical  	chemical  	 JJ	I-NP
compounds 	compounds 	 NN	I-NP
,  	,  	 ,	O
based  	based  	 VBN	O
on  	on  	 IN	O
empirical  	empirical  	 JJ	B-NP
rules  	rules  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
Lipinski 	Lipinski 	 NNP	O
's  	's  	 POS	O
rule  	rule  	 NN	B-NP
of  	of  	 IN	I-NP
five  	five  	 CD	I-NP
( 	( 	 -LRB-	O
Ro5 	Ro5 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
over  	over  	 IN	O
a  	a  	 DT	O
decade 	decade 	 NN	O
,  	,  	 ,	O
Ro5  	Ro5  	 NNP	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
combinatorial  	combinatorial  	 VB	O
compounds 	compounds 	 NNS	O
,  	,  	 ,	O
drugs  	drugs  	 NNS	O
and  	and  	 CC	O
ligands 	ligands 	 NN	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
search  	search  	 NN	O
for  	for  	 IN	O
suitable  	suitable  	 JJ	O
lead  	lead  	 NN	B-NP
compounds 	compounds 	 NN	I-NP
.  	.  	 .	O
Unfortunately 	Unfortunately 	 RB	O
,  	,  	 ,	O
till  	till  	 IN	O
date 	date 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
clear  	clear  	 JJ	O
distinction  	distinction  	 NN	O
between  	between  	 IN	O
drugs  	drugs  	 NNS	O
and  	and  	 CC	O
non-drugs  	non-drugs  	 NNP	B-NP
has  	has  	 VBZ	O
not  	not  	 RB	O
been  	been  	 VBN	O
achieved 	achieved 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
current  	current  	 JJ	O
trend  	trend  	 NN	O
is  	is  	 VBZ	O
to  	to  	 TO	O
seek  	seek  	 VB	O
out  	out  	 RP	O
drugs  	drugs  	 NNS	O
which  	which  	 WDT	O
show  	show  	 VBP	O
metabolite-likeness 	metabolite-likeness 	 JJ	B-NP
.  	.  	 .	O
In  	In  	 IN	O
identifying  	identifying  	 VBG	O
similar  	similar  	 JJ	O
physicochemical  	physicochemical  	 JJ	B-NP
characteristics 	characteristics 	 NNS	I-NP
,  	,  	 ,	O
compounds  	compounds  	 NNS	O
have  	have  	 VBP	O
usually  	usually  	 RB	O
been  	been  	 VBN	O
clustered  	clustered  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
some  	some  	 DT	O
characteristic 	characteristic 	 NN	O
,  	,  	 ,	O
to  	to  	 TO	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
search  	search  	 NN	B-NP
space  	space  	 NN	I-NP
presented  	presented  	 VBN	O
by  	by  	 IN	O
large  	large  	 JJ	O
molecular  	molecular  	 JJ	B-NP
datasets 	datasets 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
paper  	paper  	 NN	O
examines  	examines  	 VBZ	O
the  	the  	 DT	O
similarity  	similarity  	 NN	O
of  	of  	 IN	O
current  	current  	 JJ	O
drug  	drug  	 NN	B-NP
molecules  	molecules  	 NNS	I-NP
with  	with  	 IN	O
human  	human  	 JJ	O
metabolites  	metabolites  	 NN	B-NP
and  	and  	 CC	O
toxins 	toxins 	 NN	O
,  	,  	 ,	O
using  	using  	 VBG	O
a  	a  	 DT	O
range  	range  	 NN	O
of  	of  	 IN	O
computed  	computed  	 JJ	O
molecular  	molecular  	 JJ	B-NP
descriptors  	descriptors  	 NN	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
comparison  	comparison  	 NN	O
to  	to  	 TO	O
clustered  	clustered  	 VB	O
data  	data  	 NNS	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
searches  	searches  	 NNS	O
against  	against  	 IN	O
complete  	complete  	 JJ	O
datasets 	datasets 	 NN	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
have  	have  	 VBP	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
statistical  	statistical  	 JJ	O
and  	and  	 CC	O
substructure  	substructure  	 JJ	O
functional  	functional  	 JJ	B-NP
group  	group  	 NN	I-NP
analyses  	analyses  	 NNS	I-NP
of  	of  	 IN	O
three  	three  	 CD	O
datasets 	datasets 	 NN	B-NP
,  	,  	 ,	O
namely  	namely  	 RB	O
human  	human  	 JJ	O
metabolites 	metabolites 	 NN	B-NP
,  	,  	 ,	O
drugs  	drugs  	 NNS	O
and  	and  	 CC	O
toxin  	toxin  	 NN	O
molecules 	molecules 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
distributions  	distributions  	 NNS	B-NP
of  	of  	 IN	O
various  	various  	 JJ	O
molecular  	molecular  	 JJ	B-NP
descriptors  	descriptors  	 NN	I-NP
were  	were  	 VBD	O
investigated 	investigated 	 VBN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
analyses  	analyses  	 JJ	B-NP
show  	show  	 NN	I-NP
that 	that 	 IN	O
,  	,  	 ,	O
although  	although  	 IN	O
the  	the  	 DT	O
three  	three  	 CD	O
groups  	groups  	 NNS	O
are  	are  	 VBP	O
distinct 	distinct 	 JJ	O
,  	,  	 ,	O
present-day  	present-day  	 JJ	O
drugs  	drugs  	 NNS	O
are  	are  	 VBP	O
closer  	closer  	 JJR	O
to  	to  	 TO	O
toxin  	toxin  	 NN	O
molecules  	molecules  	 NNS	O
than  	than  	 IN	O
to  	to  	 TO	O
metabolites 	metabolites 	 VB	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
these  	these  	 DT	O
distributions  	distributions  	 NNS	B-NP
are  	are  	 VBP	O
quite  	quite  	 RB	O
similar  	similar  	 JJ	O
for  	for  	 IN	O
both  	both  	 DT	O
clustered  	clustered  	 JJ	O
data  	data  	 NNS	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
complete  	complete  	 JJ	O
or  	or  	 CC	O
unclustered  	unclustered  	 JJ	B-NP
datasets 	datasets 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
property  	property  	 NN	B-NP
space  	space  	 NN	I-NP
occupied  	occupied  	 VBD	O
by  	by  	 IN	O
metabolites  	metabolites  	 NN	B-NP
is  	is  	 VBZ	O
dissimilar  	dissimilar  	 VBN	O
to  	to  	 TO	O
that  	that  	 DT	O
of  	of  	 IN	O
drugs  	drugs  	 NNS	O
or  	or  	 CC	O
toxin  	toxin  	 NN	O
molecules 	molecules 	 NNS	O
,  	,  	 ,	O
with  	with  	 IN	O
current  	current  	 JJ	O
drugs  	drugs  	 NNS	O
showing  	showing  	 VBG	O
greater  	greater  	 JJR	O
similarity  	similarity  	 NN	O
to  	to  	 TO	O
toxins  	toxins  	 VB	O
than  	than  	 IN	O
to  	to  	 TO	O
metabolites 	metabolites 	 VB	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
empirical  	empirical  	 JJ	B-NP
rules  	rules  	 NNS	I-NP
like  	like  	 IN	O
Ro5  	Ro5  	 NNP	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
refined  	refined  	 VBN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
drugs  	drugs  	 NNS	O
or  	or  	 CC	O
drug-like  	drug-like  	 JJ	B-NP
molecules  	molecules  	 NNS	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
clearly  	clearly  	 RB	O
distinct  	distinct  	 JJ	O
from  	from  	 IN	O
toxic  	toxic  	 JJ	B-NP
compounds  	compounds  	 NN	I-NP
and  	and  	 CC	O
more  	more  	 RBR	O
metabolite-like 	metabolite-like 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
inclusion  	inclusion  	 NN	O
of  	of  	 IN	O
human  	human  	 JJ	O
metabolites  	metabolites  	 NN	B-NP
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
provides  	provides  	 VBZ	O
a  	a  	 DT	O
deeper  	deeper  	 JJR	O
insight  	insight  	 NN	O
into  	into  	 IN	O
metabolite 	metabolite 	 CD	B-NP
/ 	/ 	 CD	I-NP
drug 	drug 	 NN	I-NP
/ 	/ 	 CD	I-NP
toxin-like  	toxin-like  	 JJ	I-NP
properties  	properties  	 NNS	I-NP
and  	and  	 CC	O
will  	will  	 MD	O
also  	also  	 RB	O
prove  	prove  	 VB	O
to  	to  	 TO	O
be  	be  	 VB	O
valuable  	valuable  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
prediction  	prediction  	 NN	O
or  	or  	 CC	O
optimization  	optimization  	 NN	B-NP
of  	of  	 IN	O
small  	small  	 JJ	O
molecules  	molecules  	 NNS	O
as  	as  	 IN	O
ligands  	ligands  	 NN	B-NP
for  	for  	 IN	I-NP
therapeutic  	therapeutic  	 JJ	I-NP
applications 	applications 	 NNS	I-NP
.  	.  	 .	O
